Hypoglycemic Effects of a Dietary Supplement With Inositols, Gymnema Silvestre, Alpha-lactalbumin and Zinc.

Hypoglycemic Effects of a Dietary Supplement That Combines the Properties of Myo-inositol and D-chiro-inositol With Gymnema Silvestre, Alpha-lactalbumin and Zinc.

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT05348304

Acronym

EUDIA_22

Enrollment

Registered

2022-04-27

Start date

2022-06-28

Completion date

2022-10-12

Last updated

2022-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolism Disorder

Brief summary

This study is aimed at evaluating the hypoglycemic effects of a dietary supplement that associates the properties of two inositols (myo-inositol and D-chiro-inositol) in the ratio 40:1 to Gymnema sylvestre, alpha-lactalbumin and zinc.

Interventions

DIETARY_SUPPLEMENTEUDIAMET

A combination of myo-inositol and D-chiro-inositol in the 40:1 ratio, Gymnema sylvestre, alpha-lactalbumin and zinc

Study design

Allocation

NON_RANDOMIZED

Intervention model

PARALLEL

Primary purpose

SUPPORTIVE_CARE

Masking

SINGLE (Subject)

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* BMI between 30 and 35 * Basal Glycemia between 100 and 125 mg/dl

Exclusion criteria

* Diabetes diagnosis * Use of food supplements containing inositols, gymnema, alpha-lactalbumin and zinc * Intolerance to inositols, gymnema, alpha-lactalbumin and zinc

Design outcomes

Primary

Measure	Time frame	Description
Insulinemia	Three time points: change in insulin levels from the baseline to three and six months	Reduction of systemic insulin levels

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026